MiPT
N-methyl-N-isopropyltryptamine
1Provenance card
the boundary, as counts
Sources
1412 with DOI
0 strong · 12 moderate · 2 weak
Compilations
22026-04-27T08:08:52.631Z
pipeline-v5 · prompt hash not recorded — run predates 2026-09
Decisions
43last ruled 2026-06-04
0 awaiting a ruling
Issued documents
62026-10-19T20:33:03.807Z
notice · info card · emergency
Searches
181 with no results
queries and counts on the build
Claims checked
5741 supported
41 supported · 16 not
Correspondence
0received
consent field ships in Phase 4
Edges
209
derivations recorded for this entity
Complete over 14 sources, 2 compilations, and 43 decisions.Not here: the private journal (never).Working material — drafts, discards, unsupported claims — is listed below and readable on the working page.Cite: psychedex.org/substances/mipt/archive
Timeline
what happened, newest first — claims, searches and artifacts stay inside Build
- 2026-10-19issueIssued emergency
- 2026-10-19issueIssued info_card
- 2026-10-19issueIssued notice
- 2026-09-07srcMetabolism of the tryptamine-derived new psychoactive substances 5-MeO-2-Me-DALT, 5-MeO-2-Me-ALCHT, and 5-MeO-2-Me-DIPT and their detectability in urine
- 2026-09-07srcStudy of the in vitro and in vivo metabolism of the tryptamine 5-MeO-MiPT using human liver microsomes and real case samples.
- 2026-09-07srcInteraction of psychoactive tryptamines with biogenic amine transporters and serotonin receptor subtypes.
- 2026-09-07srcSerotonin toxicity of serotonergic psychedelics
- 2026-09-07srcPharmaco-toxicological effects of the novel tryptamine hallucinogen 5-MeO-MiPT on motor, sensorimotor, physiological, and cardiorespiratory parameters in mice
- 2026-09-07srcDimethyltryptamine and other hallucinogenic tryptamines exhibit substrate behavior at the serotonin uptake transporter and the vesicle monoamine transporter.
- 2026-09-07srcMultiple receptors contribute to the behavioral effects of indoleamine hallucinogens
- 2026-09-07srcTolerance and Cross-Tolerance among Psychedelic and Nonpsychedelic 5-HT2A Receptor Agonists in Mice
- 2026-09-07srcA Comprehensive HPLC-MS-MS Screening Method for 77 New Psychoactive Substances, 24 Classic Drugs and 18 Related Metabolites in Blood, Urine and Oral Fluid
- 2026-09-07srcTolerance and cross-tolerance to head twitch behavior elicited by phenethylamine- and tryptamine-derived hallucinogens in mice.
- 2026-09-07srcPharmacologic Activity of Substituted Tryptamines at 5-HT2A, 5-HT2C, 5-HT1A Receptors and SERT
- 2026-09-07srcPsychedelics and the human receptorome
- 2026-09-07srcPsychotomimetic N-methyl-N-isopropyltryptamines. Effects of variation of aromatic oxygen substituents.
- 2026-09-07srcN-Methyl-N-isopropyltryptamine — WikiDoc
- 2026-09-04issueIssued emergency
- 2026-09-04issueIssued info_card
- 2026-09-04issueIssued notice
- 2026-06-04proposal41 value proposals approved togetherone review action inferred from a shared reviewer and instant — the graph records one activity per proposal
- 2026-06-04publicationPublication — backfill
- 2026-04-27revisionRevision 1
- 2026-04-27absenceSearched ClinicalTrials.gov for "MiPT N-methyl-N-isopropyltryptamine" — no results
- 2026-04-27genGeneration — pipeline-v5pipeline-v5
- 2026-04-27rungeneration run
- 2026-04-26rungeneration run
The same entries, as forms: six forms.